Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Journal of ArrhythmologyOpen Access

Balancing between clinical efficacy and economic expediency: choosing a device for cardiac resynchronization therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

DZD. А. ZorinАНА. А. НечепуренкоADA.A. Demidov

Discussion

Loading...

Member takes

Overview

Analysis assesses diagnostic methods and arrhythmogenic events in patients, suggesting combined risk assessments may enhance outcomes.

Key Points

  • Optimal patient selection and timing in evaluating cardiac resynchronization therapy effectiveness remain critical.
  • A combined risk assessment improves predictions of sudden cardiac death and guides implantation decisions effectively.
  • Differences in device implantation approaches highlight the importance of considering both ischemic and non-ischemic cardiomyopathy.
  • The study reviews unresolved issues in balancing clinical efficacy and economic factors in cardiac resynchronization therapy.

Cite This Study

Zorin et al. (2025) studied this question.

synapsesocial.com/papers/68c23caeb210217d6478a5b7https://doi.org/10.35336/va-1467
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1CRT-D or CRT-P: When There Is a Dilemma and How to Solve It2025 · 1 citations
  2. 2CRT-D or CRT-P: When There Is a Dilemma and How to Solve It2025 · 2 citations
  3. 3Identifying Patients for Cardiac Resynchronization Therapy Beyond Current Guidelines: Insights from Cardiac MRI2025
  4. 4Patient‐specific modifiers of survival benefit in cardiac resynchronization therapy ‐ A multicentre interaction analysis2025 · 1 citations
  5. 5Impact of Using Different Advanced Pacing Algorithms and Modalities on Improving the Efficacy and Response of Cardiac Resynchronization Therapy2025